Jean-Francois Geschwind, M.D.



Interventional Radiology

Board Certification

Diplomate of the American Board of Radiology


University of Pennsylvania 

Boston University School of Medicine 

University of California San Francisco 

Johns Hopkins University School of Medicine 

Yale University School of Medicine/Management 


The Dr. Gary J. Becker Young Investigator Award, Society of Cardiovascular and Interventional Radiology 

Merit Award, American Society of Clinical Oncology 

Albert Nelson Marquis Lifetime Achievement Award Who’s Who 

Boston University School of Medicine Distinguished Alumnus Award 

Wilhelm Conrad Roentgen Honorary Lecture, European Congress of Radiology 

University of California San Francisco Radiology Alumni Award 


Radiology Society of North America

American Society of Oncology

American Association for Cancer Research

Society of Interventional Radiology

Society of Interventional Oncology

International Liver Cancer Association


About Jean-Francois Geschwind, M.D.

Jean-Francois “Jeff” Geschwind M.D. has more than 20 years of clinical, research and academic experience as an interventional radiologist providing minimally invasive treatments for vascular, vein diseases, uterine fibroids and cancer. He currently serves as the Director of USA Oncology Clinics and is recognized internationally as an expert in liver cancer. 

He served as a principal investigator in over 45 clinical trials during his tenures at Johns Hopkins Hospital and as Chairman of the Department of Radiology and Biomedical Imaging, Yale University School of Medicine. There he focused on new imaging technology, device development, drug delivery platform, combination therapy of systemic drug and loco-regional intervention, and translational studies from bench to clinic. Through his work on many investigational products, he has also accumulated a vast amount of experience interacting with the FDA. 

Dr. Geschwind has published over 300 scientific articles, three books and received numerous awards for improving therapies for patients with cancer, in particular chemoembolization and radioembolization. 

He is recognized as a key opinion leader in the field of interventional radiology and has received numerous foundation, industry, and federal grants for his research.

Schedule Online